Latest news for Rubis (OTC:RUBSF) Stock

Rubis SCA specializes in bulk liquid storage and the distribution of petroleum products. The company's operated businesses are Rubis Terminal, Rubis Energie, and Rubis Support and Services. Rubis Terminal stores, and Rubis Renouvelables. Its customers include energy and chemical groups, energy traders, and hypermarkets. The company's business segments are; Energy Distribution and Renewable Electricity Production. The majority of its revenue is generated from the Energy Distribution segment, which includes the retail and distribution of fuels, heating oils, lubricants, liquefied gases, and bitumen, as well as logistics, which includes trading supply, refining activity, and shipping. Geographically, the company derives maximum revenue from the Caribbean followed by Africa and Europe.

News

Intraday Update

Markets

Movers

Trading Ideas

ACGL

ACIA

ACMR

ACRE

ADYEY

ADYYF

AFFY

AJRD

ALCO

ALLE

ALMFF

AMADY

AMBC

AMED

AMRC

AMWD

ANSS

AOIFF

AOSL

APAM

ARDC

ARMK

ARVN

ASAZY

ASMLF

ATCMF

ATLC

ATLKY

ATRC

AXELF

BBDC

BCPC

BF-B

BIOS

BLDP

BLDR

BMBYF

BMCH

BRK-A

BRK-B

BRKR

BTBIF

BTDPY

BURBY

CACI

CCLAY

CCOI

CCXI

CDAY

CFFA

CGNX

CHRYY

CIADF

COHU

COLL

CPIVF

CPRT

CRVL

CSGP

CSLLY

Stocks That Hit 52-Week Highs On Thursday

AAPL

ACLS

ADBE

ADSK

AGRO

AIQUY

AJMPF

ALGT

APTO

APTV

ARDX

ASMIY

ATVI

AWWI

AXAHF

AXAHY

AZNCF

BABA

BANF

BHLB

BMTC

BNDSY

BRBR

BXMT

CBRE

CBSH

CHGS

CIVB

CMRE

CROX

CRTX

DIOD

EFSC

ELTZ

ENLAY

ENTG

EPAY

ESKYF

ESSYY

Eaton Vance Tax-Managed Diversified Equity

Eaton Vance Tax-Managed Global Diversified Equit

Stocks That Hit 52-Week Highs On Friday

Rubis SCA

Investors with a lot of money to spend have taken a bullish stance on Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PG, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 12 options trades for Procter &amp; Gamble.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 25%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $26,070, and 11, calls, for a total amount of $628,100.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $180.0 for Procter &amp; Gamble over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Procter &amp; Gamble's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter &amp; Gamble's whale trades within a strike price range from $150.0 to $180.0 in the last 30 days. 
<h3>Procter &amp; Gamble 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721326561_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.9</td>
<td>$170.00</td>
<td>$105.3K</td>
<td>6.2K</td>
<td style="text-align: right;">79</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$8.3</td>
<td>$8.3</td>
<td>$8.3</td>
<td>$165.00</td>
<td>$73.0K</td>
<td>2.9K</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/19/24</td>
<td>$14.8</td>
<td>$14.35</td>
<td>$14.55</td>
<td>$155.00</td>
<td>$72.7K</td>
<td>942</td>
<td style="text-align: right;">11</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$2.64</td>
<td>$2.19</td>
<td>$2.64</td>
<td>$167.50</td>
<td>$68.6K</td>
<td>1.4K</td>
<td style="text-align: right;">117</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$21.0</td>
<td>$20.6</td>
<td>$21.0</td>
<td>$150.00</td>
<td>$63.0K</td>
<td>307</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About Procter &amp; Gamble</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. P&amp;G sold its last remaining food brand, Pringles, to Kellogg in calendar 2012. Sales outside its home turf represent around 53% of the firm's consolidated total.
Having examined the options trading patterns of Procter &amp; Gamble, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Procter &amp; Gamble's Current Market Status</h3>
<ul>
<li>With a volume of 2,834,682, the price of PG is up 0.11% at $169.62. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 12 days.</li>
</ul>
<h3>Professional Analyst Ratings for Procter &amp; Gamble</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $184.0.
<ul>
<li>Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Procter &amp; Gamble, targeting a price of $183. </li>
<li>In a cautious move, an analyst from Exane BNP Paribas downgraded its rating to Outperform, setting a price target of $187. </li>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Procter &amp; Gamble, targeting a price of $190. </li>
<li>Maintaining their stance, an analyst from Deutsche Bank continues to hold a Buy rating for Procter &amp; Gamble, targeting a price of $176. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Procter &amp; Gamble with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Procter & Gamble's Options Frenzy: What You Need to Know

Deep-pocketed investors have adopted a bullish approach towards Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in EL usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Estee Lauder Cos. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 33% bearish. Among these notable options, 2 are puts, totaling $68,580, and 7 are calls, amounting to $326,565.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $95.0 to $140.0 for Estee Lauder Cos over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Estee Lauder Cos's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Estee Lauder Cos's substantial trades, within a strike price spectrum from $95.0 to $140.0 over the preceding 30 days.
<h3>Estee Lauder Cos 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721326556_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$13.5</td>
<td>$13.4</td>
<td>$13.5</td>
<td>$105.00</td>
<td>$76.9K</td>
<td>77</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>EL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$19.3</td>
<td>$17.9</td>
<td>$18.2</td>
<td>$95.00</td>
<td>$69.1K</td>
<td>43</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>EL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$18.0</td>
<td>$17.1</td>
<td>$17.69</td>
<td>$105.00</td>
<td>$61.1K</td>
<td>90</td>
<td style="text-align: right;">11</td>
</tr>
<tr>
<td>EL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$17.4</td>
<td>$17.1</td>
<td>$17.3</td>
<td>$110.00</td>
<td>$43.2K</td>
<td>2.1K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>EL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$2.45</td>
<td>$2.35</td>
<td>$2.4</td>
<td>$115.00</td>
<td>$42.0K</td>
<td>853</td>
<td style="text-align: right;">329</td>
</tr>
</tbody>
</table>

<h3>About Estee Lauder Cos</h3>
Estee Lauder is a leader in the global prestige beauty market, participating across skin care (52% of 2023 sales), makeup (28%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 28% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 33% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Having examined the options trading patterns of Estee Lauder Cos, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Estee Lauder Cos's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 2,461,496, the EL's price is down by -2.4%, now at $98.26. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 29 days.</li>
</ul>
<h3>Professional Analyst Ratings for Estee Lauder Cos</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $131.6.
<ul>
<li>Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Estee Lauder Cos, targeting a price of $108. </li>
<li>An analyst from JP Morgan persists with their Overweight rating on Estee Lauder Cos, maintaining a target price of $129. </li>
<li>Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Market Perform rating on Estee Lauder Cos with a target price of $115. </li>
<li>Consistent in their evaluation, an analyst from Goldman Sachs keeps a Neutral rating on Estee Lauder Cos with a target price of $115. </li>
<li>An analyst from DA Davidson persists with their Buy rating on Estee Lauder Cos, maintaining a target price of $191. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Estee Lauder Cos with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Estee Lauder Cos Unusual Options Activity

High-rolling investors have positioned themselves bearish on Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in FUTU often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for Futu Hldgs. This is not a typical pattern.
The sentiment among these major traders is split, with 25% bullish and 75% bearish. Among all the options we identified, there was one put, amounting to $39,750, and 7 calls, totaling $282,645.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $120.0 for Futu Hldgs during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Futu Hldgs's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Futu Hldgs's significant trades, within a strike price range of $50.0 to $120.0, over the past month.
<h3>Futu Hldgs Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721326551_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.5</td>
<td>$12.45</td>
<td>$12.45</td>
<td>$65.00</td>
<td>$59.7K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">176</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$12.8</td>
<td>$12.15</td>
<td>$12.75</td>
<td>$65.00</td>
<td>$49.7K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.55</td>
<td>$12.05</td>
<td>$12.45</td>
<td>$65.00</td>
<td>$46.0K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">102</td>
</tr>
<tr>
<td>FUTU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.66</td>
<td>$2.65</td>
<td>$2.65</td>
<td>$50.00</td>
<td>$39.7K</td>
<td style="text-align: right;">595</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.05</td>
<td>$12.7</td>
<td>$12.7</td>
<td>$65.00</td>
<td>$36.8K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>

<h3>About Futu Hldgs</h3>
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Having examined the options trading patterns of Futu Hldgs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Futu Hldgs</h3>
<ul>
<li>Currently trading with a volume of 781,241, the FUTU's price is down by -1.15%, now at $63.08. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 35 days.</li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Futu Hldgs with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

FUTU

Decoding Futu Hldgs's Options Activity: What's the Big Picture?

Dividends

Allegiant Suspends Quarterly Cash Dividend Effective Immediately In Anticipation Of Capital Requirements For Fleet Investments

Wolfe Research analyst Doug Leggate initiates coverage on Magnolia Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGY#NYSE">MGY</a>) with a Outperform rating.

Initiation

Analyst Ratings

Wolfe Research Initiates Coverage On Magnolia Oil & Gas with Outperform Rating

Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) backed OpenAI is introducing an affordable and compact version of its <a target="_blank" href="https://www.benzinga.com/topic/artificial-intelligence" rel="noreferrer noopener">advanced AI model</a>, aiming to attract a broader spectrum of developers and businesses.
The new model, named GPT-4o mini, offers a cost-effective alternative to the highly capable GPT-4o.
The San Francisco-based company said that GPT-4o mini will be available immediately for free users, as well as ChatGPT Plus and Team subscribers, with enterprise customers gaining access next week.
This new model replaces GPT-3.5 Turbo in ChatGPT, <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-07-18/openai-releases-gpt-4o-mini-a-cheaper-version-of-flagship-ai-model?srnd=technology-vp&amp;sref=TBDibEcD" rel="noreferrer noopener">Bloomberg</a> reports. Originally unveiled in May, GPT-4o <a target="_blank" href="https://www.benzinga.com/news/24/05/38809935/openai-just-dropped-gpt-4o-and-these-10-examples-show-it-could-completely-change-ai-chatbot-game" rel="noreferrer noopener">was designed to function</a> as a superior digital assistant capable of processing audio and visual information in real time.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/07/39763462/whistleblowers-accuse-openai-of-hindering-staff-from-reporting-ai-risks" rel="noreferrer noopener">Whistleblowers Accuse OpenAI Of Hindering Staff From Reporting AI Risks</a>
GPT-4o mini retains much of this functionality, with more features planned for future updates.
Developers have been testing GPT-4o mini over the past week. For example, email startup Superhuman used it to create automated email replies, and financial services startup Ramp utilized it to extract information from receipts.
AI companies like Anthropic and Alphabet Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google often release smaller, less expensive versions of their top models to provide more options for developers, according to Bloomberg.
Smaller models are suitable for automating basic tasks, while larger models handle more complex functions. This strategy allows developers to choose the most appropriate tool for their needs.
Initially, GPT-4o mini can process and generate text and images, and it is the first model to use a new safety method called "instruction hierarchy," designed to prioritize certain instructions, such as those from a company, to prevent misuse.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39722083/chatgpt-parent-openai-and-atomic-bomb-fame-los-alamos-join-forces-to-explore-ais-potential-in-scient" target="_blank" rel="noreferrer noopener">ChatGPT-Parent OpenAI And Atomic Bomb-Fame Los Alamos Join Forces To Explore AI's Potential In Scientific Research</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

Media

General

GOOGL

MSFT

ChatGPT Parent OpenAI Unveils GPT-4o Mini - A Cost-Effective AI Model For Developers

Wolfe Research analyst Doug Leggate reinstates Marathon Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) with a Outperform.

Wolfe Research Reinstates Outperform on Marathon Petroleum

President Joe Biden and former President Donald Trump are, <a href="https://www.benzinga.com/general/politics/24/07/39844101/pelosi-tells-biden-he-cant-beat-trump-shell-do-everything-in-her-power-to-prevent-2024-run">as of now</a>, set to square off in a fierce rematch of the 2020 election. As betting markets show Trump having a substantial advantage over Biden, how would solar stocks far under <a href="https://www.benzinga.com/topic/donald-trump">a second Trump term</a>?
Benzinga&#8217;s readers weighed in. &#8220;Would you buy solar stocks ahead of a Trump/[J.D.] Vance win, given their historical skepticism towards the solar industry and support for fossil fuels?&#8221; Benzinga asked. The results show varying opinions among investors.
<ul>
<li>43% of respondents said yes.</li>
<li>57% of respondents said no.</li>
</ul>
Now Read: <a href="https://www.benzinga.com/government/24/07/39841598/project-2025-wants-to-radically-change-us-tax-policy-would-you-pay-more-or-less-in-taxes">Project 2025 Wants To Radically Change US Tax Policy — Would You Pay More Or Less In Taxes?</a>
Trump&#8217;s odds of winning the presidency have risen steadily in 2024, <a href="https://polymarket.com/event/presidential-election-winner-2024?tid=1721323060397">according</a> to betting market Polymarket. Meanwhile, in a move perhaps correlated with the election, solar stocks are down on the year.
Trump repeatedly criticized solar and wind energy during his presidency, <a href="https://www.newsweek.com/donald-trump-criticizes-solar-power-windmills-turn-television-1370707">according</a> to Newsweek. He also <a href="https://www.nytimes.com/2016/11/19/world/asia/china-trump-climate-change.html">called</a> climate change a &#8220;hoax.&#8221;
The Invesco Solar ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>), which tracks solar energy companies, is down 18.32% in 2024. It is down over 4% since <a href="https://www.benzinga.com/government/24/07/39778541/trump-shooting-recalls-memories-of-reagan-assassination-attempt-heres-how-markets-react-to-political">the assassination attempt</a> on Trump on July 13 (betting markets predicted that Trump&#8217;s <a href="https://www.benzinga.com/general/politics/24/07/39780356/trumps-2024-election-betting-odds-hit-record-high-after-assassination-attempt-payouts-for-ex-pre">odds of winning</a> the election increased substantially following the event).
First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), Enphase Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) and Canadian Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) all <a href="https://www.benzinga.com/news/24/07/39776035/solar-stocks-tumble-following-failed-assassination-of-trump-whats-going-on">took major hits</a> in the market session following the assassination attempt. Since then, their performance has varied. Canadian Solar has recovered while Enphase and First Solar have sunk further in the red.
Republicans are seen to <a href="https://www.benzinga.com/government/24/07/39692871/trumps-deregulation-agenda-oil-gas-defense-and-finance-stocks-may-benefit-from-loose-rules-goldman-s">be more partial</a> to gas and oil than solar. Both sectors have done well under the Biden administration: The U.S. produced more oil under Biden <a href="https://www.benzinga.com/government/23/10/35240230/us-is-producing-more-oil-under-biden-than-at-any-point-under-the-trump-administration">than at any point under Trump</a>, and Biden <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/39087879/what-a-biden-or-trump-victory-might-mean-for-the-energy-sector">has approved billions</a> in incentives for clean energy while in office.
Meanwhile, solar has paradoxically <a href="https://www.benzinga.com/markets/esg/24/05/39012502/california-loses-the-solar-crown-whos-americas-new-energy-star">become more popular</a> in states such as Texas (a state that consistently votes red,) which could indicate that solar has become less politicized.
The survey was conducted by Benzinga on July 16 and July 17 and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 112 adults.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/24/07/39837570/unemployment-claims-rise-more-than-expected-boosting-hopes-for-rate-cuts-as-cracks-in-labor-mark" target="_blank" rel="noreferrer noopener">Unemployment Claims Rise More Than Expected, Boosting Hopes For Rate Cuts As Cracks In Labor Market Emerge</a></li>
</ul>

Equities

Politics

ETFs

CSIQ

ENPH

FSLR

EXCLUSIVE: Would A Trump Victory Help Or Hurt Solar Stocks? Benzinga Poll Shows Investors Divided

Scientists at George Washington University School of Medicine and Health Sciences recently discovered that CBD can help protect skin from sun damage.  
"We have some great evidence that, when delivered in a meaningful way, cannabidiol can have an important impact on skin health," Dr. Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences said.
A <a href="https://www.jaad.org/article/S0190-9622(24)02490-3/fulltext" target="_blank" rel="noreferrer noopener">study</a> published in the Journal of the American Academy of Dermatology examined how cannabidiol (CBD) protects the skin from ultraviolet-A radiation (UVA). CBD is a non-psychoactive compound found in the cannabis plant. The study concluded CBD can help against mtDNA mutations associated with UVA-induced skin aging.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39141685/cbd-rich-cannabis-oil-improves-social-behavior-by-acting-on-love-hormone-pathway-new-study" target="_blank" rel="noreferrer noopener">CBD-Rich Cannabis Oil Improves Social Behavior By Acting On ‘Love Hormone' Pathway, New Study</a>
<h2 class="wp-block-heading">Study Highlights</h2>
The researchers focused on how CBD has anti-inflammatory and antioxidant properties that could mitigate damage from UVA exposure. UVA radation contributes to photoaging by causing inflammation and oxidative damage, scientists wrote.
To test how effective CBD is in protecting skin from sun damage, researchers asked 19 participants to apply nano-CBD (nCBD) or vehicle (VC) cream to their buttocks twice a day for 14 days. Nano-CBD is CBD processed into very small nanoparticles, typically less than 100 nanometers in size and is used for better bioavailability and absorption.
The participants were then exposed to three times the amount of ultraviolet radiation that normally causes damage. After 24 hours, the volunteers&#8217; buttocks were biopsied for a thorough examination, including histology and immuno-histochemistry.
The analyses showed that 21% of participants had less observed erythema on CBD-treated skin than VC skin. Erythema is redness of the skin caused by increased blood flow in superficial capillaries It occurs with any skin injury, infection or inflammation.
More importantly, the study results also showed that 50% of the people treated with CBD had no DNA damage from the UV exposure, Friedman said, <a href="https://wtop.com/health-fitness/2024/07/gw-study-finds-cbd-may-help-prevent-skin-damage-from-the-sun/" target="_blank" rel="noreferrer noopener">according to </a>Wtop News.
<h2 class="wp-block-heading">More Research Needed</h2>
The small sample size was one of the limitations of the study. Friedman added that further research should be done to reveal how CBD can be used to protect against skin damage caused by the sun. Even though sunscreen is still the best way to protect the skin, Friedman pointed out that there are still areas of the skin that will be damaged. He said he hoped that CBD can help prevent this damage.
"I look at this nano-CBD as the cleanup. … It can help repair and protect our DNA from the harmful effects of UV radiation," he said.
"While this is the most involved study and the largest study of its kind, certainly more research is needed to really find out where CBD delivered in this unique way has a place in managing healthy skin and protecting against the harmful effects of the environment like the sun," Friedman concluded.
In addition to GW's School of Medicine, the study was conducted by the Center for Clinical and Cosmetic Research in Florida.
<h2 class="wp-block-heading">Similar Research</h2>
This research is similar to a recent study that suggested <a href="https://www.benzinga.com/markets/cannabis/24/06/39168516/new-study-suggests-cannabis-sativa-extracts-could-help-prevent-or-reverse-sun-damage" target="_blank" rel="noreferrer noopener">cannabis sativa extracts might help prevent or treat sun damage</a>. Scientists looked at how an extract derived from the leaves of cannabis sativa exhibits the potential to prevent and reverse photoaging (sun damage) by suppressing the overproduction of pro-inflammatory proteins and enzymes connected to collage degradation.
Photoaging happens with prolonged overexposure to the sun, which can cause the skin to age prematurely and, in some cases, lead to skin cancer. According to the <a href="https://www.who.int/news-room/fact-sheets/detail/ultraviolet-radiation#:~:text=Excessive%20exposure%20to%20UVR%20caused,skin%20in%20the%20year%202020." target="_blank" rel="noreferrer noopener">World Health Organization</a>, skin cancer is one of the most common forms of cancer in the world and in the U.S. Some 90% of non-melanoma skin cancers are linked to exposure to the sun's ultraviolet (UV) radiation. These UV rays can burn and damage skin without the feeling of getting warm.
Read Next:
<ul>
<li><a href="https://drupal-cloudfront.benzinga.com/markets/cannabis/24/07/39657007/cannabis-linked-to-diabetes-prevention-and-better-blood-sugar-control-new-study-finds" target="_blank" rel="noreferrer noopener">Cannabis Linked To Diabetes Prevention And Better Blood Sugar Control, New Study Finds</a></li>
</ul>
Photo: Courtesy of supwach tongchaidach via Shutterstock

Cannabis

Study Shows CBD Could Protect Skin From Sun Damage By Exposing Participants To 3X UV Radiation

US Appeals Court Blocks New Biden Administration Student Debt Relief Plan

Wolfe Research analyst Doug Leggate reinstates Matador Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTDR#NYSE">MTDR</a>) with a Peer Perform.

MTDR

Wolfe Research Reinstates Peer Perform on Matador Resources

ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) shares are trading higher by 0.56% to $75.89 during Thursday&#8217;s session. With Taiwan Semiconductor Mfg. Co. Ltd. surpassing <a href="https://www.benzinga.com/news/earnings/24/07/39833542/apple-nvidia-supplier-tsmc-stock-rises-in-thursdays-premarket-after-crashing-8-in-last-session-what">second-quarter earnings expectations</a>, semiconductor stocks are recovering following Wednesday&#8217;s selloff. On Wednesday, the sector experienced a decline due to speculations about President Biden potentially imposing <a href="https://www.benzinga.com/markets/equities/24/07/39813495/why-key-apple-nvidia-supplier-tsmcs-shares-are-plunging-in-wednesdays-premarket">more restrictions</a> on China. This comes alongside Republican nominee Donald Trump&#8217;s remarks about the China-Taiwan conflict during a Bloomberg interview.
Trump's remarks about Taiwan controlling "100% of our chip business" emphasize the substantial reliance of the U.S. semiconductor industry on Taiwanese manufacturing. This dependence raises concerns about possible supply chain disruptions, particularly amidst geopolitical tensions between China and Taiwan.
Geopolitical risks surrounding TSMC can generate negative sentiment that spills over to other semiconductor companies, including ON Semi. Investors may become anxious about the stability of the supply chain and potential disruptions in the future.
Read Also:&nbsp;<a href="https://www.benzinga.com/government/24/07/39841598/project-2025-wants-to-radically-change-us-tax-policy-would-you-pay-more-or-less-in-taxes">Project 2025 Wants To Radically Change US Tax Policy: Would You Pay More Or Less In Taxes?</a>
<h2 class="wp-block-heading">Is ON A Good Stock To Buy?</h2>
An investor or trader's decision to buy or sell a stock is unique to their time horizon and risk tolerance. Many typical investors evaluate earnings growth and valuation on a particular stock before making a decision. 
For example, for ON Semiconductor, you'll notice that earnings in its last quarter grew 3.85% <a href="https://www.benzinga.com/quote/ON/earnings">source</a>. As an investor, you'll want to decide whether that's better or worse than what you'd like to see among stocks in your portfolio. 
On the valuation side, ON Semiconductor's price to earnings ratio &#8211; a measure of how much an investor pays for the company's earnings &#8211; is projected to compress 37.05% in the current quarter when compared with last year. That places it below similar businesses NVIDIA, Taiwan Semiconductor, Broadcom in its sector. You'll need to decide whether that makes it more or less attractive based on how you think the company will perform over time.
There are many different valuation metrics that may help you make a decision. Find more on <a href="https://www.benzinga.com/quote/ON">ON Semiconductor's quote page</a>, or if you'd like a deeper dive in an advanced program, try <a href="https://pro.benzinga.com">Benzinga PRO</a> for free.
ON has a 52-week high of $111.35 and a 52-week low of $59.34.

What's Going On With ON Semiconductor Stock?

Wolfe Research analyst Doug Leggate reinstates Murphy Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) with a Peer Perform.

Wolfe Research Reinstates Peer Perform on Murphy Oil

It&#8217;s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market&#8217;s fear gauge, spiked over 10%, reaching levels last seen in late April.
Both the S&amp;P 500 and the Nasdaq 100 indices declined by 0.6%, while the Dow Jones Industrial Average fell 0.7%, potentially ending a streak of <a href="https://www.benzinga.com/top-stories/24/07/39827103/dow-jones-extends-all-time-highs-blue-chips-post-strongest-6-day-gain-versus-tech-stocks-in-22-years">six consecutive positive sessions.</a>
Small-cap stocks also succumbed to the broader negative sentiment, with the Russell 2000 index dropping 0.7%.
Chicago Fed President Austan Goolsbee, a known &#8220;dove&#8221; on the board, expressed optimism about progress on inflation and the U.S. economy&#8217;s resilience in avoiding a recession. He did not commit to a potential <a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39843875/feds-goolsbee-confident-with-inflations-golden-path-but-wont-tie-committee-hands-">rate cut in September.</a>
Following Wednesday&#8217;s sell-off triggered by concerns over increased U.S. chip export restrictions to China, semiconductor stocks remained broadly weaker, with the iShares Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NYSE">SOXX</a>) down by 0.6%. Despite this, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) defied the trend, rising 1.8%.
Significant volatility erupted in the health care sector, particularly within the weight loss drug industry. The market duopoly of Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) and Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) face heightened competitive threats from Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and Roche Holding Ltd (OTCPK: RHHBY), both of which recently announced developments to enter this lucrative market.
Shares of Eli Lilly plunged 5.6%, marking their worst session since mid-March 2021, while Novo Nordisk shares dropped 5%, their worst performance since August 2022.
On the economic data front, jobless claims rose more than expected last week and continuing claims reached their highest level since November 2021, indicating a cooling trend <a href="https://www.benzinga.com/etfs/sector-etfs/24/07/39837570/unemployment-claims-rise-more-than-expected-boosting-hopes-for-rate-cuts-as-cracks-in-labor-mark">in the labor market.</a>
The U.S. dollar acted as a safe haven, rising 0.3%, while Treasury yields inched higher across the curve. The European Central Bank kept interest rates unchanged, as expected, keeping the <a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39838605/european-central-bank-holds-interest-rates-unchanged-keeps-markets-guessing-on-se">door open for September.</a>
In commodities, growth-sensitive copper tumbled over 3%, hitting its lowest level since mid-April. Silver eased by 0.9% and gold remained flat. Oil prices slipped 0.3%, while natural gas surged over 4%, nearly recouping Wednesday&#8217;s sharp losses following a weaker-than-expected buildup in inventories last week.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged 0.4% lower, eyeing a second consecutive negative close.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,687.70</td>
<td>-0.6%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,556.41</td>
<td>-0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,929.46</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,220.63</td>
<td>-0.7%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071824&amp;t=be2bearmibe3na1">Benzinga pro</a> data: 
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;was 0.6% lower to $553.74.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;fell by 0.7% to $409.10.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(ARCA:&nbsp;<a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a><a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a>QQQ) fell 0.5% to $479.14.</li>
<li>Sector-wise, the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)&nbsp;outperformed, up by 1%, while the&nbsp;Health Care Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 1.5%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Market Movers</h3>
<ul>
<li>Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) fell 0.9% despite reporting stronger-than-expected results last quarter.</li>
<li>Other stocks reacting to corporate earnings were Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>), down 3.5%, Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>), down 1%, SL Green Realty Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) down 2.5%, Kinder Morgan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>), up 3.8%, Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>), down 13%, Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), up 2.6%, Marsh &amp; McLennan Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), down 1%, Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>), down over 5%, Cintas Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>), up over 6%, D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), up 13%, Virtu Financial Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>), up 18% and Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>), down 4.4%.</li>
<li>Companies reporting after the close include Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) and Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/government/24/07/39841598/project-2025-wants-to-radically-change-us-tax-policy-would-you-pay-more-or-less-in-taxes">Project 2025 Wants To Radically Change US Tax Policy: Would You Pay More Or Less In Taxes?</a></li>
</ul>
Photo via Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Large Cap

Macro Economic Events

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Health Care

Commodities

Treasuries

Econ #s

Economics

Federal Reserve

$BTC

CTAS

SPDR Dow Jones Industrial Average ETF Trust

ISRG

NFLX

NVDA

RHHBY

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

VIRT

VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?

On Wednesday, Pfizer Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and Valneva SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) announced that the participants of the Phase 3 VALOR trial have completed the primary vaccination series (three doses) of Lyme disease <a target="_blank" href="https://www.benzinga.com/general/biotech/22/08/28408141/pfizer-and-valneva-commence-late-stage-lyme-disease-study" rel="noreferrer noopener">vaccine candidate VLA15</a>.
Lyme disease is a bacterial infection that can be spread to humans by infected ticks.
Participants will be monitored for the occurrence of Lyme disease cases until the end of the Lyme disease season in 2025.
"VLA15, the Lyme disease vaccine candidate we are co-developing with Valneva, is the one which has advanced the furthest along the clinical development timeline, with two Phase 3 trials in progress," said Annaliesa Anderson, Ph.D., Senior Vice President and Head of Vaccine Research and Development, Pfizer.
The Pfizer-sponsored VALOR trial is <a target="_blank" href="https://valneva.com/press-release/phase-3-valor-lyme-disease-trial-valneva-and-pfizer-announce-primary-vaccination-series-completion/" rel="noreferrer noopener">conducted</a> at sites where Lyme disease is highly endemic across the U.S., Canada, and Europe.
The trial aims to evaluate the efficacy, safety, tolerability, immunogenicity, and lot consistency of VLA15, a 6-valent OspA-based Lyme <a target="_blank" href="https://www.benzinga.com/general/biotech/22/04/26814244/valneva-pfizer-post-encouraging-data-from-lyme-disease-vaccine-candidate" rel="noreferrer noopener">disease vaccine candidate</a>.
Trial participants aged five years and older were randomized 1:1 into two trial groups. They received four doses of either VLA15 or a saline placebo – one dose each at months 0, 2, 5-9 and a booster one year after the third dose, shortly before the peak of the next Lyme disease season.
Pfizer plans to submit marketing applications with the FDA and the European Medicines Agency in 2026.
VLA15 has shown a favorable safety profile in all clinical trials across all dose and age groups.
An independent Data Safety Monitoring Board (DSMB) has observed no safety concerns in any treatment group to date.
A second Phase 3 trial (C4601012) is ongoing, aiming to provide further evidence on the safety profile of VLA15 in the pediatric population between 5 and 17 years of age. The trial completed enrollment in June 2023.
Pfizer and Valneva entered into a collaboration agreement in April 2020 to co-develop VLA15, with updates to the terms within this <a target="_blank" href="https://www.benzinga.com/general/biotech/23/09/34307656/pfizer-valnevas-tick-borne-infection-shot-companies-say-positive-result-for-lyme-disease-vaccine-" rel="noreferrer noopener">agreement made in June 2022</a>.
Price Action: At last check Thursday, VALN stock was down 0.46% at $7.70, and PFE stock was up 0.50% at $30.18.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39842882/agenus-loses-more-than-50-value-on-thursday-heres-why" target="_blank" rel="noreferrer noopener">Agenus Loses More Than 50% Value On Thursday &#8211; Here's Why</a></li>
</ul>
Image via Unsplash

Biotech

VALN

Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026

Wolfe Research analyst Doug Leggate reinstates Ovintiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) with a Outperform.

Wolfe Research Reinstates Outperform on Ovintiv

Wolfe Research analyst Doug Leggate reinstates Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) with a Outperform.

Wolfe Research Reinstates Outperform on Occidental Petroleum

Google's Parent Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) stock is trading lower today. The Italian Competition Authority has launched an investigation into Google and its parent company Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), regarding their methods for obtaining user consent for linking <a target="_blank" href="https://en.agcm.it/en/media/press-releases/2024/7/PS12714" rel="noreferrer noopener">data across various services</a>.
The probe focuses on how Google requests consent from users to link data across its services, such as Google Search, YouTube, Chrome, and Maps.
The Italian regulator suspects that Google may provide inadequate or misleading information about the effects of this consent.
The Authority alleges that Google's consent requests might lack transparency about the scope and implications of combining user data across multiple services. This could lead users to unknowingly consent to broader data use than intended.
The investigation also examines whether Google employs techniques that could influence consumer decisions.
The Authority is concerned that these methods might pressure users into consenting to data practices they might otherwise reject.
In response to the investigation, a Google spokesperson stated, "We will analyze the details of this case and will work cooperatively with the Authority," <a target="_blank" href="https://techcrunch.com/2024/07/18/google-accused-of-misleading-consumers-to-grab-more-data-for-ads/" rel="noreferrer noopener">TechCrunch</a> reports.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/07/39822184/google-and-microsoft-provide-nvidia-chip-access-to-chinese-firms-despite-u-s-restrictions-report" rel="noreferrer noopener">Google And Microsoft Provide Nvidia Chip Access To Chinese Firms Despite U.S. Restrictions: Report</a>
Google has been subject to the <a target="_blank" href="https://www.benzinga.com/government/24/03/37911506/apple-meta-and-googles-alphabet-under-scrutiny-eu-launches-antitrust-probes" rel="noreferrer noopener">EU's Digital Markets Act (DMA) </a>since early March, which mandates that companies obtain explicit consent before processing users' personal data for advertising or combining data from different services.
The DMA, which includes <a target="_blank" href="https://www.benzinga.com/topic/digital-markets-act" rel="noreferrer noopener">regulations that align </a>with the General Data Protection Regulation (GDPR), requires consent to be "freely given, specific, informed, and unambiguous."
This investigation could have significant implications for how Google manages user data within the European Union.
However, Google has announced some of the changes including a new search page layout for European users, with dedicated aggregator units with links to aggregator sites from <a target="_blank" href="https://www.benzinga.com/news/24/03/37507425/from-search-to-flights-google-tweaks-everything-for-eus-digital-markets-act" rel="noreferrer noopener">across the web to comply with the DMA</a>.
Italy's investigation also touches on the broader issue of "dark patterns" in online consent flows, where design techniques can manipulate users into making choices they might not otherwise make.
The EU's Digital Services Act (DSA) bans such deceptive designs, aiming to protect users' ability to make free and informed decisions.
Alphabet stock has gained about 43% in the last 12 months. Investors can gain exposure to the stock via the&nbsp;Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) and Vanguard Communication Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOX#NYSE">VOX</a>).
Price Action: GOOGL shares are trading lower by 1.62% at $179.65 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39820669/google-parent-alphabets-q2-expected-to-shine-with-ai-youtube-shorts-cloud-strength-analyst" target="_blank" rel="noreferrer noopener">Google Parent Alphabet's Q2 Expected To Shine With AI, YouTube Shorts, Cloud Strength: Analyst</a></li>
</ul>
Photo by Pawel Czerwinski on Unsplash.

GOOG

What's Going On With Google's Parent Alphabet Stock On Thursday?

Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $71.5, with a high estimate of $82.00 and a low estimate of $64.00. This upward trend is evident, with the current average reflecting a 6.11% increase from the previous average price target of $67.38.
<img src="https://www.benzinga.com/files/images/story/2024/1721325658_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Equity Residential. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brent Dilts</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$82.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Alexander Goldfarb</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$73.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Anthony Paolone</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$68.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$69.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Vikram Malhorta</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$64.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$72.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Adam Kramer</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Brent Dilts</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$75.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>In-Line</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Alexander Goldfarb</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>John Kim</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$68.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Equity Residential. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Equity Residential compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Equity Residential's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EQR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equity Residential analyst ratings.</a>
<h2>Discovering Equity Residential: A Closer Look</h2>
Equity Residential owns a portfolio of 302 apartment communities with around 80,000 units and is developing two additional properties with 537 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
<h3>Unraveling the Financial Story of Equity Residential</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Equity Residential's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 3.65%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Equity Residential's net margin is impressive, surpassing industry averages. With a net margin of 40.2%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Equity Residential's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.66%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Equity Residential's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.47% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Equity Residential's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.68.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For Equity Residential

In the preceding three months, 13 analysts have released ratings for Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>), presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $11.77, along with a high estimate of $23.00 and a low estimate of $5.00. A 27.84% drop is evident in the current average compared to the previous average price target of $16.31. 
<img src="https://www.benzinga.com/files/images/story/2024/1721325652_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Shoals Technologies Gr by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jon Windham</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$10.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Mark Strouse</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$23.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Chris Dendrinos</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Vikram Bagri</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Sell</td>
<td>$5.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$12.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Jeffrey Osborne</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$11.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Derek Soderberg</td>
<td>Cantor Fitzgerald</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$14.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$11.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Donovan Schafer</td>
<td>Northland Capital Markets</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$6.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Maheep Mandloi</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Buy</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Philip Shen</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Philip Shen</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Buy</td>
<td>$15.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Shoals Technologies Gr. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Shoals Technologies Gr compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Shoals Technologies Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Shoals Technologies Gr's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SHLS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Shoals Technologies Gr analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Shoals Technologies Gr</h2>
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.
<h3>Shoals Technologies Gr: Financial Performance Dissected</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Shoals Technologies Gr's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -13.59% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Shoals Technologies Gr's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.26% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Shoals Technologies Gr's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 0.87%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.57%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.3, Shoals Technologies Gr adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Rubis

News

Latest news for Rubis (OTC:RUBSF) Stock

Thursday, January 16, 2020

Friday, December 20, 2019